Europe

Magazine articles on conducting business in European countries.

Old Articles: <Older 1481-1490 Newer>

InternetNews October 4, 2006 Ed Sutherland	Is EC Finalizing Intel Suit? Are European regulators in the final stages of filing antitrust charges against Intel? We may know soon.
InternetNews October 3, 2006 Michael Hickins	Microsoft Appeals $357M EC Fine Microsoft has filed an appeal of the $357 million fine levied by the European Commission this summer.
The Motley Fool October 3, 2006 Brian Gorman	Britain's Psychiatric Stir-Up The U.S. government may be forced to follow Great Britain's example regarding drug reimbursements, given recent developments in Medicare. What will this mean for Big Pharma?
The Motley Fool October 3, 2006 Rich Smith	Britannia Rules the 'Wares? Britain's grocer Tesco takes on Microsoft's monopoly. Investors, take note.
Chemistry World October 2, 2006 Gill & Sanderson	RSC to Launch Open Access Hybrid Model In a move to keep RSC publishing competitive, authors of RSC journal papers can now choose to have their research freely available the moment it is published -- for a fee.
Information Today October 2, 2006 Robin Peek	The British Library Releases Intellectual Property Manifesto The British Library released a document called "Intellectual Property: A Balance - The British Library Manifesto," which tackles increasingly unforgiving intellectual property laws.
Chemistry World October 2006 Craig Fleming	Comment: Discrimination in the workplace New UK age discrimination legislation recently came into force. Employers should see it as a perfect opportunity to balance their workforce. This issue not only affects large pharmaceutical and biotechnology companies, but many small and medium sized organizations as well.
Chemistry World October 2006 Katherine Sanderson	Careers: Climbing the Academic Ladder The UK National Research Staff Association hopes to smooth the academic path for postdocs.
BusinessWeek October 9, 2006 Jason Bush	The Russian Towers Are Coming Foreign investors are getting in on projects from Moscow to Novosibirsk.
The Motley Fool September 29, 2006 Brian Lawler	Pfizer Helps France Kick Butts Europe approves the pharmaceutical's new drug to help smokers quit. Activities like this drug approval, and the molecule licensing earlier this week from privately held Quark Biotech, should eventually reignite Pfizer's moribund revenue growth.
<Older 1481-1490 Newer> Return to current articles.